Review Medical Applications
Review Medical Applications
Abstract. In the medical field, due to the obvious individual differences between patients, the
complexity of human tissues and the fact that patients are too price-sensitive, it is desperate to
search for a new biological material adjuvant therapy, which far more closely matches the
pathological characteristics of patients. It is noted that additive manufacturing has the ability to
overcome those limitations by virtue of its exclusive characteristics of personalized
customization, small-scale production and high precision. This paper aims to summarize the
characteristics and applications of 3D printing technology used at four levels in the medical field,
including adjuvant therapy and anatomical model, implants and scaffolds, biological 3D printing,
and pharmaceuticals, as well as, to present the recent innovation and discuss existing issues with
3D printing that related to medical applications. It is highlighted that 3D printing technology will
be further built on medical application.
1. Introduction
3D printing technology used to be born in the 1990s and has been extensively used in a variety of fields
such as industry, pharmacy, architecture, clothes, training [1-4]. Thanks to its blessings of precision,
quick prototyping and customization, it is now increasingly imperative to realize an individualized and
accurate therapeutic cure [5, 6]. This technology separates a 3D model into multiple layers of slices
alongside a certain set path and types a 3D object by layer by layer creation and layer by layer stacking.
Its specific flow includes acquisition of statistics, image analysis and development of models [7].
Current research on 3D printing technology for medical purposes concentrates on the following four
important areas: 1. Study on personalized manufacturing of bioactive permanent prosthesis implants and
scaffolds; 2. Study on manufacturing pathological organ models to assist preoperative planning and
surgical treatment analysis [8]; 3. Study on directly printing tissues and organs with complete life
functions [9-11]; 4. Study on versatile platform for drug delivery [12]. Although such applications
remain a long way from widespread clinical applications as several key technical and fundamental
scientific issues that are yet to be overcome, notable scientific advancements and applications have been
achieved in these areas.
Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution
of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.
Published under licence by IOP Publishing Ltd 1
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
2. 3D printing fundamentals
2
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
wearer [24]. Additive Manufacturing (AM) technology helps to enhance human life by removing the
human organ, making artificial organs, surgical instruments and accelerating surgery. Efficient contact
and substances are required in the field of medical treatment [25]. This technology is used for bioprinting
of suitable medical material. A living cell and synthetic living tissue can be developed for the medical
laboratory [26]. This makes it easier to build a surgical mesh that protects tissues and organs during
surgery. In short, a vast range of materials are used to build 3D models for the medical industry. The
various types of materials used in AM technologies are shown in table 1.
Table 1. The summary of materials used by Additive Manufacturing in the medical field.
3. Medical applications
3
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
Figure 2. (a) Stereolithographic resin model of a full skull with a custom Ti plate
in place; (b) Hip implant fabricated by SLM Solutions in Germany [47].
3.2. Pathological organ models to assist preoperative planning and surgical treatment analysis
For clinical treatment and preoperative planning, high-fidelity physical organ models are of significant
importance, and can also be used in medical education in colleges and universities, offering more
intuitive stereoscopic vision and tactile sensation for students [49]. The patient condition can only be
understood from the 2D plane by means of magnetic resonance imaging (MRI) or computed tomography
(CT) technologies due to the individual variations between patients, which cannot provide more accurate
preoperative guidance for surgery, whereas the traditional model production procedure is not only
difficult, but also not appropriate for rapid prototype modeling.
Whereas the advent of 3D printing can overcome these problems easily, prior to surgery, physicians
are able to conduct surgery preparation and diagnosis using 3D printed models. In addition, these 3D
printed models include procedure repeatability, automate steps and make the whole operation phase
more precise, thus reducing the operation's anesthesia time and infection risk and eventually improving
the operation's success rate. Cardiovascular disease is a chronic and regularly occurring disease in
hospitals, with elevated clinical death and injury rates. Having a proper diagnosis of coronary disease
prompt and reliable is conducive to effective management of the disease, thus reducing the mortality
4
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
Figure 3. 3D printed models of heart: (a) The left and right ventricles models of the
heart and myocardial models; (b) The cardiac fibrous skeleton and various valve solid
models; (c) The assembly of components [51].
By comparing and studying the cardiac fibrous skeleton and the left and right ventricles of the heart
and their myocardial versions, we can better understand the anatomical configuration of the valve and
its spatial association with the adjacent cardiac chambers. The nervous system comprises primarily the
central nervous system and the peripheral nervous system. There are a host of disorders in the central
nervous system, including multiple pathogenesis. In clinical practice, the occurrence of illness may have
a significant effect on the health of patients and may also jeopardize the wellbeing of patients.
Chen et al. [52] used the photographs collected from magnetic resonance scanning to print the knee
joint disease model in order to provide orthopedic postgraduates with a more vivid and understandable
anatomical type of knee joint events, so that students can not only learn more about the causes, diagnosis
and treatment of the disease, but also better understand the anatomical parts, the spatial arrangement, g.
Around the same time, they can follow the surgical criteria and execute simulation surgery experiments
so that students can discover information that are not technically accessible and improve their knowledge
of the disease and anatomy..
There are some drawbacks with respect to the use of realistic models for adjuvant surgery. Person
refining models have high data quality standards, so hospitals need to configure high-resolution imaging
equipment to collect relevant photographs from patients in order to generate 3D printed models.
Physicians, meanwhile, need to expend a lot of time on simulating and planning surgery before surgery,
which prolongs treatment time and is not appropriate for emergency surgery. Therefore, the
implementation is only at the initial level of discovery.
5
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
can result in the deposition of various types of cells of different densities at different locations of the
scaffold and directly printing tissues or organs [53, 54].
Bioprinting is generally primarily limited to the printing of blood vessels, skin and organs, although
the complexity of printing tissues and organs focuses mostly on the internal fluid vascular network [19].
Laronda et al. [55] suggested a system for the rehabilitation of ovarian mice using gelatin hydrogel-
printed artificial bio-microporous scaffolding (Figure 4). As a 3D bioprinting hydrogel material, it is
also important to balance its mechanical behavior so that it can fulfill the requirements of both printing
and cell growth. To fix this problem, the team used the partial cross-linking properties of gelatin at a
certain temperature (Figure 4a) to print smooth and continuous hydrogel filaments and completely cross-
linked the hydrogel to the cooling table to accurately print complex microporous scaffolds (Figure 4b)
suitable for follicle growth. The scaffold was used to grow follicles and to further produce the artificial
biological ovaries that could be prepared and inserted in the missing sections of the mice ovaries. This
technology will rebuild the ovaries of the mouse and restore their function (Figure 4c).
Dolati et al. [56] used MWCNT-reinforced alginate and typical alginate to make vascular catheters
successful. The manufactured vascular catheters have a length of more than 1 m and have a strong
perfusion capacity and high permeability, and can allow the media to diffuse radially, close to natural
blood vessels. Bioprinting remains a cutting-edge approach to the growing international scarcity of
organs, and the opportunity for transplant tissues and organs with a low risk of immune response is
expected.
6
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
[63]. This technology therefore provides a more sophisticated method for the engineering of
pharmaceutical devices.
Channeled systems have been investigated to optimize the release of medications from immediate
release formulations (Figure 5a) [64]. By controlling the different aspects of the channels (e.g. width,
length and configuration), the release of drugs could be tailored to meet the required specification. The
development of such complex geometries using traditional manufacturing methods is a challenge.
Similarly, caplets containing internal holes, referred to as gaplets, are developed to facilitate separation
of fast-release tablets and to prevent the need for disintegrants (Figure 5b) [65]. In contrast, 3D printed
networks with controlled release properties and differing densities were also manufactured [66].
Figure 5. Schematic illustration: (a) Channelled caplets; (b) Gaplets prepared using FDM
3D printing [64, 65].
FDM 3D printing technology can also be used to build hollow capsule shells with separate dual
compartments [67]. Each compartment may be constructed of the same or different materials and/or
thicknesses. Since these compartments are precisely sealed, they can be filled with powders or even
liquids [68]. This research is important for the development of personalized drug delivery systems
combining various medications (e.g. metformin and glimepiride [69]) or doses of drugs, in particular
because drugs can be co-formulated even though they are chemically incompatible. In comparison to
traditional manufacturing technologies, FDM 3D printing technology allows on-demand manufacture
of personalized patient-specific dose drug products with reliable dosing, high reproducibility and good
mechanical properties.
In addition, the processing of complex dosage forms may be accomplished, such as through
accommodating a broad variety of polymeric matrices and active ingredients, or through designing
dosage forms that show personalized effects or target particular organs. The technology has further
progressed, making it easier to integrate it with other innovations in order to build more dynamic and
smart distribution mechanisms.
4. Conclusion
Additive Manufacturing (AM) technology is at a flourishing level, and its uses in adjuvant surgery,
permanent prosthesis replacements and rehabilitation medical equipment are becoming more and more
mature. Applying 3D printing to adjuvant therapy can help physicians optimize surgery preparation,
promote diagnostic and preoperative instruction, develop doctor-patient contact, and assist in teaching
research to increase the success rate of surgery. The individualized implant is more consistent with the
initial anatomical form, which increases patient satisfaction and aesthetics following surgery and is
helpful for postoperative rehabilitation. Medical use of direct printing of tissues and organs may resolve
the problems of loss of organ donor and immune rejection.
While 3D printing technology has already been realized in clinical applications, the expense of 3D
printing technology is still limited. The material support is insufficient, the types of printable materials
7
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
are few, the price of biocompatible materials is high, and the price of 3D printing equipment and high-
resolution imaging equipment are equally high, making research and development (R&D) and
verification in clinical applications costly. In comparison, contrary to traditional approaches, there are a
range of relevant comprehensive laws and regulations to guide this technology in getting it closer to the
consumer. In fact, there are still many obstacles in the technological sector, while the cells can be directly
printed at this point, it is still a long way to extend the concept of vitro tissues to clinical applications.
Many similar studies have concentrated on the issue of processing, but there is a lack of breakthrough
in the area of functionalization and implementation, and there is still a bottleneck in the development of
complex organs. As an evolving technology, 3D printing continues to be implemented in the medical
sector and has made a major contribution to clinical work, but there are also many problems that need
to be tackled, such as the ongoing advancement of science and technology, continuous investment in
relevant research, upgrading and changing management and regulatory frameworks, their success and
application in practice.
Acknowledgments
This research work is strongly supported by the Structural Performance Materials Engineering
(SUPREME) Focus Group and the Human Engineering (HEG) Focus Group, Universiti Malaysia
Pahang, and School of Mechanical Engineering, Ningxia University, which provided the research
materials and equipment.
References
[1] Vanderploeg A, Lee S-E and Mamp M 2017 The application of 3D printing technology in the
fashion industry International Journal of Fashion Design, Technology and Education 10 170-9
[2] Ventola C L 2014 Medical applications for 3D printing: current and projected uses Pharmacy
and Therapeutics 39 704
[3] Li D Z, Chen Z Y and Zhong J X 2019 Review on the Research and Practice of Construction
3D Printing in China from the Perspective of Multiple Participation Journal of Civil
Engineering and Mangement 36 1-7
[4] Zhang J L and Zhang J B 2016 The Application of 3D Printing Technology in the Innovation
and Entrepreneurship Education in Colleges and Universities Journal of Zhangjiakou
Vocational and Technical College 29 60-3
[5] Iannotti J P, Weiner S, Rodriguez E, Subhas N, Patterson T E, Jun B J and Ricchetti E T 2015
Three-dimensional imaging and templating improve glenoid implant positioning JBJS 97 651-
8
[6] Li S H, Deng C, Zhou M W and Fu Z B 2018 Concepts, characteristics and values of precision
medicine in the field of orthopedics Chinese Journal of Tissue Engineering Research 22 2407
[7] Rengier F, Mehndiratta A, Von Tengg-Kobligk H, Zechmann C M, Unterhinninghofen R,
Kauczor H-U and Giesel F L 2010 3D printing based on imaging data: review of medical
applications International journal of computer assisted radiology and surgery 5 335-41
[8] Butscher A, Bohner M, Doebelin N, Hofmann S and Müller R 2013 New depowdering-friendly
designs for three-dimensional printing of calcium phosphate bone substitutes Acta biomaterialia
9 9149-58
[9] Derby B 2012 Printing and prototyping of tissues and scaffolds Science 338 921-6
[10] Saunders R E, Gough J E and Derby B 2008 Delivery of human fibroblast cells by piezoelectric
drop-on-demand inkjet printing Biomaterials 29 193-203
[11] Xu T, Zhao W, Zhu J-M, Albanna M Z, Yoo J J and Atala A 2013 Complex heterogeneous
tissue constructs containing multiple cell types prepared by inkjet printing technology
Biomaterials 34 130-9
[12] Berman B 2012 3-D printing: The new industrial revolution Business horizons 55 155-62
[13] Quanjin M, Rejab M, Idris M, Kumar N M, Abdullah M and Reddy G R 2020 Recent 3D and
4D intelligent printing technologies: A comparative review and future perspective Procedia
8
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
9
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
10
IPCME 2021 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 1078 (2021) 012007 doi:10.1088/1757-899X/1078/1/012007
drug-delivery systems using hot melt extrusion: A new approach for individualized therapy
Therapeutic Delivery 8 957-66
[59] Pietrzak K, Isreb A and Alhnan M A 2015 A flexible-dose dispenser for immediate and extended
release 3D printed tablets European journal of pharmaceutics and biopharmaceutics 96 380-7
[60] Solanki N G, Tahsin M, Shah A V and Serajuddin A T 2018 Formulation of 3D printed tablet
for rapid drug release by fused deposition modeling: screening polymers for drug release, drug-
polymer miscibility and printability Journal of pharmaceutical sciences 107 390-401
[61] Verstraete G, Samaro A, Grymonpré W, Vanhoorne V, Van Snick B, Boone M, Hellemans T,
Van Hoorebeke L, Remon J P and Vervaet C 2018 3D printing of high drug loaded dosage
forms using thermoplastic polyurethanes International journal of pharmaceutics 536 318-25
[62] Goyanes A, Fina F, Martorana A, Sedough D, Gaisford S and Basit A W 2017 Development of
modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive
manufacturing International journal of pharmaceutics 527 21-30
[63] Goyanes A, Buanz A B, Hatton G B, Gaisford S and Basit A W 2015 3D printing of modified-
release aminosalicylate (4-ASA and 5-ASA) tablets European Journal of Pharmaceutics and
Biopharmaceutics 89 157-62
[64] Sadia M, Arafat B, Ahmed W, Forbes R T and Alhnan M A 2018 Channelled tablets: An
innovative approach to accelerating drug release from 3D printed tablets Journal of Controlled
Release 269 355-63
[65] Arafat B, Wojsz M, Isreb A, Forbes R T, Isreb M, Ahmed W, Arafat T and Alhnan M A 2018
Tablet fragmentation without a disintegrant: A novel design approach for accelerating
disintegration and drug release from 3D printed cellulosic tablets European Journal of
Pharmaceutical Sciences 118 191-9
[66] Korte C and Quodbach J 2018 3D-printed network structures as controlled-release drug delivery
systems: dose adjustment, API release analysis and prediction AAPS PharmSciTech 19 3333-
42
[67] Maroni A, Melocchi A, Parietti F, Foppoli A, Zema L and Gazzaniga A 2017 3D printed multi-
compartment capsular devices for two-pulse oral drug delivery Journal of Controlled Release
268 10-8
[68] Markl D, Zeitler J A, Rasch C, Michaelsen M H, Müllertz A, Rantanen J, Rades T and Bøtker
J 2017 Analysis of 3D prints by x-ray computed microtomography and terahertz pulsed imaging
Pharmaceutical research 34 1037-52
[69] Gioumouxouzis C I, Baklavaridis A, Katsamenis O L, Markopoulou C K, Bouropoulos N,
Tzetzis D and Fatouros D G 2018 A 3D printed bilayer oral solid dosage form combining
metformin for prolonged and glimepiride for immediate drug delivery European Journal of
Pharmaceutical Sciences 120 40-52
11